MedTrace Logo

Dismantling the Components and Dosing of CBT for Co-Occurring Disorders

NCT02161211 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-02-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to establish a brief CBT intervention that can largely, if not fully eliminate the deleterious effect of common co-occurring anxiety disorders on alcohol use disorder treatment outcomes.

Conditions

  • CBT Decoupling
  • CBT Anxiety Reduction
  • CBT Combined

Interventions

BEHAVIORAL

De-coupling

Six sessions of CBT for anxiety-alcohol de-coupling

BEHAVIORAL

Anxiety Reduction

Six sessions of CBT for anxiety reduction.

BEHAVIORAL

Combined

Three sessions devoted to anxiety reduction and to anxiety-alcohol de-coupling each.

Sponsors & Collaborators

Principal Investigators

  • Matt Kushner, PhD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2020-02-19
Completion
2020-06-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02161211 on ClinicalTrials.gov